|
|
|
|
LEADER |
03446nam a22004575i 4500 |
001 |
6200 |
003 |
DE-He213 |
005 |
20130725190443.0 |
007 |
cr nn 008mamaa |
008 |
100301s2009 gw | s |||| 0|eng d |
020 |
# |
# |
|a 9783540692973
|9 978-3-540-69297-3
|
024 |
7 |
# |
|a 10.1007/978-3-540-69297-3
|2 doi
|
050 |
# |
4 |
|a RC254-282
|
072 |
# |
7 |
|a MJCL
|2 bicssc
|
072 |
# |
7 |
|a MED062000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.994
|2 23
|
100 |
1 |
# |
|a Senn, Hans-Jr̲g.
|e editor.
|
245 |
1 |
0 |
|a Cancer Prevention II
|c edited by Hans-Jr̲g Senn, Ursula Kapp, Florian Otto.
|h [electronic resource] /
|
264 |
# |
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg,
|c 2009.
|
300 |
# |
# |
|b online resource.
|
336 |
# |
# |
|a text
|b txt
|2 rdacontent
|
337 |
# |
# |
|a computer
|b c
|2 rdamedia
|
338 |
# |
# |
|a online resource
|b cr
|2 rdacarrier
|
347 |
# |
# |
|a text file
|b PDF
|2 rda
|
490 |
1 |
# |
|a Recent Results in Cancer Research,
|v 181
|x 0080-0015 ;
|
505 |
0 |
# |
|a From the contents Cancer Prevention and Health Politics -- Cancer Prevention: The Scientific-Epidemiological Base. Energy metabolism, cancer risk, and cancer prevention. Promises and limitations of biomarkers -- Cancer Prevention, Tobacco and Nutrition -- Cancer Prevention, Genetics and Vaccines -- Breast Cancer. The use of Tamoxifen and Raloxifene for the prevention of breast cancer. Prevention of ER-negative breast cancer. Exogenous and endogenous hormones, mammographic density and breast cancer risk -- Cancer of the Digestive Tract. Chemoprevention of oesophageal cancer -- Prostate Cancer. Review of diagnostic markers for prostate cancer. Selenium and vitamin E cancer prevention trial. Prostate cancer prevention by short-term anti-androgens -- Cancer Prevention: Metabolic Aspects. Anti-angiogenic activity of oleanic acid terpenoids -- Aspirin and NSAIDs in Cancer Prevention. Pharmacologic effects of NSAIDs. Aspirin and NSAIDs for the prevention of colorectal cancer.
|
520 |
# |
# |
|a This Recent Results in Cancer Research volume contains the majority of the invited expert contributions of the Fifth International Conference on Cancer Prevention, held 6<U+0013>8 March 2008 at the University of St. Gallen, Switzerland. Written by some of the world<U+0019>s leading experts in the field, the volume constitutes a comprehensive update on the most important and recent developments in molecular biology and cancer genetics, regarding chiefly the upsurging, but still controversial, field of primary prevention, especially chemoprevention. This conference primarily addressed the four leading and most frequent solid tumor types - breast, colon, gynecological, and lung cancer - all of which demonstrate how such an approach is currently possible and important in clinical cancer prevention research. The future prospects of chemoprevention and the process of selecting the most successful target populations at risk are discussed.
|
650 |
# |
0 |
|a Medicine.
|
650 |
# |
0 |
|a Oncology.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Cancer Research.
|
700 |
1 |
# |
|a Kapp, Ursula.
|e editor.
|
700 |
1 |
# |
|a Otto, Florian.
|e editor.
|
710 |
2 |
# |
|a SpringerLink (Online service)
|
773 |
0 |
# |
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9783540692966
|
830 |
# |
0 |
|a Recent Results in Cancer Research,
|v 181
|x 0080-0015 ;
|
856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-540-69297-3
|
912 |
# |
# |
|a ZDB-2-SME
|
950 |
# |
# |
|a Medicine (Springer-11650)
|